Currently, there are 844.20M common shares owned by the public and among those 837.44M shares have been available to trade.
The company’s stock has a 5-day price change of -6.24% and -4.81% over the past three months. AGNC shares are trading -5.10% year to date (YTD), with the 12-month market performance up to 19.97% higher. It has a 12-month low price of $7.33 and touched a high of $10.85 over the same period. AGNC has an average intraday trading volume of 16.98 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.56%, -9.01%, and -5.34% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of AGNC Investment Corp (NASDAQ: AGNC) shares accounts for 36.32% of the company’s 844.20M shares outstanding.
It has a market capitalization of $7.86B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 6.52, while the earnings-per-share (ttm) stands at $1.43. The company has a debt-to-equity ratio at 8.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.25% over the week and 1.65% over the month.
Earnings per share for the fiscal year are expected to decrease by -25.06%, and -11.71% over the next financial year. EPS should grow at an annualized rate of -3.56% over the next five years, compared to -24.53% over the past 5-year period.
Looking at the support for the AGNC, a number of firms have released research notes about the stock. Wells Fargo stated their Overweight rating for the stock in a research note on September 20, 2024, with the firm’s price target at $10-$12. Janney was of a view on June 06, 2024 that the stock is Buy, while Compass Point gave the stock Buy rating on February 20, 2024, issuing a price target of $10.25. UBS on their part issued Neutral rating on December 06, 2023.
